FDA Class II Device Recall: GEM Premier 5000 PAK
Summary
The FDA has initiated a Class II device recall for Instrumentation Laboratory's GEM Premier 5000 PAK (Part No. 00055407511) due to Process Control Solution Not Detected (PCSND) errors. The recall affects worldwide distribution, including the US.
What changed
The FDA has classified a recall of the GEM Premier 5000 PAK (Part No. 00055407511) as Class II, indicating that use of or exposure to the affected product may cause temporary or medically reversible adverse health consequences. The recall is due to confirmed customer complaints of increased Process Control Solution Not Detected (PCSND) errors during warm-up, leading to GEM PAK ejection. This issue requires the insertion of a new cartridge.
Healthcare providers and medical device distributors who have distributed or used the affected GEM Premier 5000 PAKs must be aware of this recall. While the document does not specify immediate actions for users, they should consult Instrumentation Laboratory's recall notification for specific instructions regarding product return, replacement, or other remediation steps. The recall affects worldwide distribution, including the US, Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, and Switzerland, among others.
What to do next
- Review recall notification from Instrumentation Laboratory for specific instructions.
- Identify and segregate affected GEM Premier 5000 PAKs.
- Follow manufacturer's instructions for product return or replacement.
Source document (simplified)
Instrumentation Laboratory
Device Recalls (Class II)
← All Device Recalls (Class II) Class II Z-1531-2026 · 20260318 · Ongoing
Product
GEM Premier 5000 PAK; Part No. 00055407511.
Reason for Recall
Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of ...
Distribution
Worldwide distribution - US Nationwide and the countries of Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, Switzerland, Canada,...
Source: openFDA Enforcement API
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when FDA: Device Recalls Class II publishes new changes.